Research Directory Details | National Medical Research Register

A multi-center, open label trial to demonstrate the clinical effectiveness and safety of Gengraf® and Prograf® in Renal Transplant patients

A multi-center, open label trial to demonstrate the clinical effectiveness and safety of Gengraf® and Prograf® in Renal Transplant patients

Gengraf-Prograf Trial

General Information
Research Type
Interventional
Description
This is a multi-center, open label, single treatment arm trial designed to demonstrate the clinical effectiveness and safety of Gengraf® and Prograf®.
120 patients with de novo renal allograft from about 16 participating sites who meet inclusion/ex
Study Information
RMK Priority Area
Research Level
Research Keyword
Inclusion & Exclusion Criteria
Inclusion Criteria
Exclusion Criteria
Study Timeline
Expected / Actual Date Study Starts - First Enrolment of subject / Collecting data
Jan, 02 2003
Expected / Actual Date Study Completed
Jun, 09 2005
Expected / Actual Duration of Study Enrollment / Data Collection
127 weeks